FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W74993898> ?p ?o ?g. }

• W74993898 endingPage "900" @default.
• W74993898 startingPage "2895" @default.
• W74993898 abstract "Curcumin (diferuloylmethane), a yellow substance from the root of the plant Curcuma longa Linn., has been demonstrated to inhibit carcinogenesis of murine skin, stomach, intestine and liver. However, the toxicology, pharmacokinetics and biologically effective dose of curcumin in humans have not been reported. This prospective phase-I study evaluated these issues of curcumin in patients with one of the following five high-risk conditions: 1) recently resected urinary bladder cancer; 2) arsenic Bowen's disease of the skin; 3) uterine cervical intraepithelial neoplasm (CIN); 4) oral leucoplakia; and 5) intestinal metaplasia of the stomach. Curcumin was taken orally for 3 months. Biopsy of the lesion sites was done immediately before and 3 months after starting curcumin treament. The starting dose was 500 mg/day. If no toxicity > or = grade II was noted in at least 3 successive patients, the dose was then escalated to another level in the order of 1,000, 2,000, 4,000, 8,000, and 12,000 mg/day. The concentration of curcumin in serum and urine was determined by high pressure liquid chromatography (HPLC). A total of 25 patients were enrolled in this study. There was no treatment-related toxicity up to 8,000 mg/day. Beyond 8,000 mg/day, the bulky volume of the drug was unacceptable to the patients. The serum concentration of curcumin usually peaked at 1 to 2 hours after oral intake of crucumin and gradually declined within 12 hours. The average peak serum concentrations after taking 4,000 mg, 6,000 mg and 8,000 mg of curcumin were 0.51 +/- 0.11 microM, 0.63 +/- 0.06 microM and 1.77 +/- 1.87 microM, respectively. Urinary excretion of curcumin was undetectable. One of 4 patients with CIN and 1 of 7 patients with oral leucoplakia proceeded to develop frank malignancies in spite of curcumin treatment. In contrast, histologic improvement of precancerous lesions was seen in 1 out of 2 patients with recently resected bladder cancer, 2 out of 7 patients of oral leucoplakia, 1 out of 6 patients of intestinal metaplasia of the stomach, I out of 4 patients with CIN and 2 out of 6 patients with Bowen's disease. In conclusion, this study demonstrated that curcumin is not toxic to humans up to 8,000 mg/day when taken by mouth for 3 months. Our results also suggest a biologic effect of curcumin in the chemoprevention of cancer." @default.
• W74993898 created "2016-06-24" @default.
• W74993898 creator A5004338713 @default.
• W74993898 creator A5007314789 @default.
• W74993898 creator A5007688770 @default.
• W74993898 creator A5009766509 @default.
• W74993898 creator A5010929981 @default.
• W74993898 creator A5016005429 @default.
• W74993898 creator A5019094542 @default.
• W74993898 creator A5022848547 @default.
• W74993898 creator A5029171331 @default.
• W74993898 creator A5030421346 @default.
• W74993898 creator A5038862062 @default.
• W74993898 creator A5041750265 @default.
• W74993898 creator A5047543850 @default.
• W74993898 creator A5052101902 @default.
• W74993898 creator A5058692722 @default.
• W74993898 creator A5066815139 @default.
• W74993898 creator A5069107505 @default.
• W74993898 creator A5082229312 @default.
• W74993898 creator A5087015001 @default.
• W74993898 creator A5087726368 @default.
• W74993898 creator A5091496269 @default.
• W74993898 date "2001-11-20" @default.
• W74993898 modified "2023-10-03" @default.
• W74993898 title "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions." @default.
• W74993898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11712783" @default.
• W74993898 hasPublicationYear "2001" @default.
• W74993898 type Work @default.
• W74993898 sameAs 74993898 @default.
• W74993898 citedByCount "600" @default.
• W74993898 countsByYear W749938982012 @default.
• W74993898 countsByYear W749938982013 @default.
• W74993898 countsByYear W749938982014 @default.
• W74993898 countsByYear W749938982015 @default.
• W74993898 countsByYear W749938982016 @default.
• W74993898 countsByYear W749938982017 @default.
• W74993898 countsByYear W749938982018 @default.
• W74993898 countsByYear W749938982019 @default.
• W74993898 countsByYear W749938982020 @default.
• W74993898 countsByYear W749938982021 @default.
• W74993898 countsByYear W749938982022 @default.
• W74993898 countsByYear W749938982023 @default.
• W74993898 crossrefType "journal-article" @default.
• W74993898 hasAuthorship W74993898A5004338713 @default.
• W74993898 hasAuthorship W74993898A5007314789 @default.
• W74993898 hasAuthorship W74993898A5007688770 @default.
• W74993898 hasAuthorship W74993898A5009766509 @default.
• W74993898 hasAuthorship W74993898A5010929981 @default.
• W74993898 hasAuthorship W74993898A5016005429 @default.
• W74993898 hasAuthorship W74993898A5019094542 @default.
• W74993898 hasAuthorship W74993898A5022848547 @default.
• W74993898 hasAuthorship W74993898A5029171331 @default.
• W74993898 hasAuthorship W74993898A5030421346 @default.
• W74993898 hasAuthorship W74993898A5038862062 @default.
• W74993898 hasAuthorship W74993898A5041750265 @default.
• W74993898 hasAuthorship W74993898A5047543850 @default.
• W74993898 hasAuthorship W74993898A5052101902 @default.
• W74993898 hasAuthorship W74993898A5058692722 @default.
• W74993898 hasAuthorship W74993898A5066815139 @default.
• W74993898 hasAuthorship W74993898A5069107505 @default.
• W74993898 hasAuthorship W74993898A5082229312 @default.
• W74993898 hasAuthorship W74993898A5087015001 @default.
• W74993898 hasAuthorship W74993898A5087726368 @default.
• W74993898 hasAuthorship W74993898A5091496269 @default.
• W74993898 hasConcept C112705442 @default.
• W74993898 hasConcept C126322002 @default.
• W74993898 hasConcept C126894567 @default.
• W74993898 hasConcept C2777230291 @default.
• W74993898 hasConcept C2778250585 @default.
• W74993898 hasConcept C2779422922 @default.
• W74993898 hasConcept C29730261 @default.
• W74993898 hasConcept C556039675 @default.
• W74993898 hasConcept C71924100 @default.
• W74993898 hasConcept C90924648 @default.
• W74993898 hasConcept C98274493 @default.
• W74993898 hasConceptScore W74993898C112705442 @default.
• W74993898 hasConceptScore W74993898C126322002 @default.
• W74993898 hasConceptScore W74993898C126894567 @default.
• W74993898 hasConceptScore W74993898C2777230291 @default.
• W74993898 hasConceptScore W74993898C2778250585 @default.
• W74993898 hasConceptScore W74993898C2779422922 @default.
• W74993898 hasConceptScore W74993898C29730261 @default.
• W74993898 hasConceptScore W74993898C556039675 @default.
• W74993898 hasConceptScore W74993898C71924100 @default.
• W74993898 hasConceptScore W74993898C90924648 @default.
• W74993898 hasConceptScore W74993898C98274493 @default.
• W74993898 hasIssue "4B" @default.
• W74993898 hasLocation W749938981 @default.
• W74993898 hasOpenAccess W74993898 @default.
• W74993898 hasPrimaryLocation W749938981 @default.
• W74993898 hasRelatedWork W2027350019 @default.
• W74993898 hasRelatedWork W2055583675 @default.
• W74993898 hasRelatedWork W2077303879 @default.
• W74993898 hasRelatedWork W2350403668 @default.
• W74993898 hasRelatedWork W2375118844 @default.
• W74993898 hasRelatedWork W2391855825 @default.
• W74993898 hasRelatedWork W2463618462 @default.

• next